Add like
Add dislike
Add to saved papers

[Corrigendum] Inhibitory activity of apogossypol in human prostate cancer in vitro and in vivo.

An interested reader drew to the attention of the Editorial Board of Molecular Medicine Reports that certain data featured in the above paper had been published in 2014 in the same journal, in an article featuring several of the same authors [Zhang X, Hu X, Mu S, Zhan Y, An Q, Liu Z and Huang X: "Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo", Mol Med Rep 10: 1184‑1194, 2014]. Specifically, data in Fig. 2A of the above paper (the Apogossypol, 15 µmol/l data panel) had appeared in Fig. 3B, c in the 2014 paper. The authors responded to our original enquiry asking for an explanation concerning the data that had been shared between these papers, and confirmed that the inclusion of the same data in the two papers had occurred in error. Subsequently, they were able to identify the proper data for the affected figure of the above paper, and a corrected version of Fig. 2 is printed here. We apologize to the readership of the Journal for any inconvenience caused. [the original article was published in the Molecular Medicine Reports 11: 4142‑4148, 2015; DOI: 10.3892/mmr.2015.3326].

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app